NetChop

NetChop predicts proteasomal cleavage sites to identify peptide fragments relevant for cytotoxic T lymphocyte (CTL) epitope generation.

Key Features:

• Neural Network-Based Prediction: Employs neural network algorithms to predict where the human proteasome will cleave precursor proteins.
• Sequence Encoding Enhancements: Updated sequence encoding methods improve predictive performance compared to prior versions.
• Improved Accuracy: The updated model predicts approximately 10% more cleavage sites while reducing false positives by nearly 15%.
• N-terminal Extension Analysis: Estimates N-terminal extensions after proteasomal cleavage and reports that over 30% of peptides have extensions of three amino acids or more.
• TAP Ligand Specificity: Indicates that peptides that are good Transporter Associated with Antigen Processing (TAP) ligands are preferentially cleaved by the proteasome.
• Epitope Identification Support: Focuses on identifying potential immunogenic regions and CTL epitopes, typically eight to ten amino acids long.

Scientific Applications:

• Epitope Prediction: Aids identification of candidate CTL epitopes derived from pathogen or host proteomes.
• N-terminal Trimming Analysis: Enables study of N-terminal extensions and the role of trimming in antigen presentation.
• TAP–Proteasome Correlation Studies: Supports analysis of the relationship between TAP ligand specificity and proteasomal cleavage preferences.
• Vaccine and Immunotherapy Target Prioritization: Assists prioritization of peptide candidates for vaccine design and immunotherapeutic interventions.

Methodology:

Computations use neural network algorithms trained with sequence encoding methods to predict human proteasome cleavage sites.